GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Natural Alternatives International Inc (FRA:NA2) » Definitions » Long-Term Capital Lease Obligation

Natural Alternatives International (FRA:NA2) Long-Term Capital Lease Obligation : €41.8 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Natural Alternatives International Long-Term Capital Lease Obligation?

Natural Alternatives International's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €41.8 Mil.

Natural Alternatives International's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (€42.9 Mil) to Dec. 2023 (€42.8 Mil) and declined from Dec. 2023 (€42.8 Mil) to Mar. 2024 (€41.8 Mil).

Natural Alternatives International's annual Long-Term Capital Lease Obligation increased from Jun. 2021 (€13.7 Mil) to Jun. 2022 (€20.3 Mil) but then declined from Jun. 2022 (€20.3 Mil) to Jun. 2023 (€17.5 Mil).


Natural Alternatives International Long-Term Capital Lease Obligation Historical Data

The historical data trend for Natural Alternatives International's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natural Alternatives International Long-Term Capital Lease Obligation Chart

Natural Alternatives International Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 16.68 13.68 20.26 17.51

Natural Alternatives International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.41 17.51 42.89 42.83 41.79

Natural Alternatives International  (FRA:NA2) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Natural Alternatives International Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Natural Alternatives International's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Natural Alternatives International (FRA:NA2) Business Description

Traded in Other Exchanges
Address
1535 Faraday Avenue, Carlsbad, CA, USA, 92008
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

Natural Alternatives International (FRA:NA2) Headlines

No Headlines